Hirschsprung disease (HD) rarely presents as chronic constipation after the newborn period. At our institution, calretinin immunohistochemistry (CAL) is frequently requested by clinicians on rectal mucosal biopsies (RMBs) taken during colonoscopy in older children in whom suspicion for HD is low. We hypothesized that review of these biopsies would frequently reveal ganglion cells (GCs). We reviewed features of mucosal biopsies (November 2013 to September 2015) from children !1 year of age on which clinicians had requested CAL on at least one specimen. A total of 93 biopsies with paired CAL from 83 patients were suitable for study (ages 1-18 years, M:F 1.2). Submitted clinical indication was constipation in 62 patients (75%). GCs were found within or subjacent to muscularis mucosa in 63 biopsies (68%), 12 (19%) of which were designated from a specific anatomic site, eg, 2 or 3 cm. In 25 of 63 (40%) cases, GCs were identified on one of the first 3 sections (median 5th, range 1st-54th). Forty-six cases (73%) contained no or <0.5 mm of submucosa (SM, range 0-2 mm). All but one case (62/63, 98%) with identified GCs showed positive CAL staining; a single case showed equivocal staining. Among the 30 biopsies with no observed GCs, none (0%) had >1 mm of SM, and 21 (70%) had no SM. CAL was positive in 28 (93%) and equivocal/weak in 2 (7%); no additional work-up for HD was pursued. The data suggest that H&E sections of RMBs can exclude HD at a specified site in many cases and provide the basis for a future study examining the utility of CAL in RMBs without SM as a means for excluding HD.
Introduction
Hirschsprung disease (HD), congenital absence of submucosal and myenteric ganglion cells (GCs) in a variable segment of distal colon, typically presents in infancy with pseudo-obstruction, enterocolitis, and/or megacolon. [1] [2] [3] Rarely, HD may manifest as chronic constipation in childhood after infancy. 4 The standard diagnostic procedure for HD is rectal suction biopsy (RSB); RSB produces a sample consisting of colonic mucosa, muscularis mucosa, and submucosa (SM) which allows the assessment of the presence or absence of submucosal GCs. 5 In addition to hematoxylin and eosin (H&E)-stained tissue sections, acetylcholinesterase histochemistry (AChE) 6, 7 and calretinin immunohistochemistry (CAL) 8, 9 on RSBs may be useful as adjuncts to assess nerves in cases clinically suspicious for HD. In children aged 1 year or older, in whom the prevalence of HD is low, pediatric gastroenterologists (PGs) usually begin treatment with laxatives and may proceed to rectal manometry. 10 RSB has proven effective in diagnosing HD from infancy through childhood, 11 though some earlier studies found it to be less effective in older children. 12, 13 For this reason, CAL staining of rectal mucosal biopsies (RMBs), without dedicated SM sampling, is frequently requested by PGs at our institution in an attempt to gain information about the ganglionic state of the biopsied site. This historical, requisitionbased request is a unique clinical scenario at our institution. In this setting, pathologists may be compelled to evaluate additional H&E-stained tissue sections in search of GCs in spite of a lack of adequate SM.
We hypothesized that review of RMBs from children aged 1 year or older on which CAL had been performed at clinician request would (1) frequently reveal GCs on H&E stain, such that aganglionosis could be definitively excluded at that particular site; (2) exclude HD if the anatomic level of the biopsy had been specified at 2 and/or 3 cm; and (3) provide preliminary data on the utility of CAL in this setting.
Methods
Following institutional review board approval, our pathology database was queried for pediatric mucosal gastrointestinal biopsies on which CAL was performed between November 2013 and September 2015. The exclusion criteria were age less than 1 year, biopsy designated ''suction,'' and specimens submitted from surgery. Archival formalin-fixed paraffin-embedded H&E-and CALstained slides produced from biopsies obtained during colonoscopy or sigmoidoscopy were retrieved for review.
Many biopsies had been prepared according to a departmental general gastrointestinal biopsy protocol, ie, 2 H&E-stained slides with 3-4 serial tissue sections per slide, each slide separated by 30-40 mm, for a total of 6-8 sections. When CAL had been requested on the specimen requisition form, a third calretinin-stained slide had been produced simultaneously. Additional H&E sections had been ordered at the original pathologist's discretion. Other biopsies had been prepared using a HD protocol in response to the requisition form request for CAL. This protocol results in 10 H&E-stained slides with 5-6 serial tissue sections per slide for a total of 50-60 sections, followed by an 11th slide with CAL section. Occasionally, additional H&E sections had been prepared at the original pathologist's discretion. Only existing materials were reviewed for this study.
Both authors reviewed all biopsies, and consensus for all data points on each biopsy was achieved. For each biopsy, the following parameters were recorded: submitted clinical indication, presence or absence of GCs, number of tissue fragments, total millimeters of mucosa, total millimeters of SM, number of H&E sections examined, H&E section on which GCs were identified, and CAL pattern (''positive,'' ''negative,'' or ''equivocal''). CAL staining was noted to vary significantly from biopsy to biopsy, including within the control tissue. A positive (non-HD pattern) interpretation was rendered in cases with strong linear staining or with weak linear staining in rare nerve twigs (see Figure 1 (C) and 1(F)); an interpretation of equivocal staining was rendered when no definite linear staining was observed by either pathologist. Total millimeters of mucosa and SM were measured parallel to the mucosal surface and muscularis mucosae on the single H&E section with the most mucosa and/or SM in the manner described in Pacheco and Bove. 7 The depth of SM was less than 1 mm in all cases. H&E sections were enumerated beginning at the labeled end of each slide as per histology laboratory protocol. Regardless of whether the slide had been prepared using the GI protocol or the HD protocol, the H&E section number on which the GCs were identified was recorded. Features of biopsies with identified GCs were compared to those without GCs.
Results
A total of 93 RMBs from 83 patients aged 1 year or older with paired CAL were identified in the 22-month study period. Patients included 46 males and 37 females (M:F ratio 1.2:1). Median age was 6.2 years (range 1-18 years). The most common submitted clinical indication was constipation in 62 of 83 patients (75%). Sample characteristics are summarized in Table 1 . Nineteen of the 93 cases (20%) had a site designation traditionally associated with HD work-ups; these included 8 cases designated ''rectum at 2 cm,'' 7 cases labeled ''rectum at 3 cm,'' and 1 case each labeled ''rectum, 2-3 cm,'' ''rectum, 3-4 cm,'' ''rectal wall at 2 mm,'' and ''rectal wall at 3 mm.'' The 2 biopsies designated as 2 mm and 3 mm most likely represent transcriptional errors. The total number of tissue sections per biopsy across the entire cohort ranged from 6 to 98 sections (median of 30 sections). Total aggregated length of mucosa per biopsy ranged from 2 to 13 mm (median 6 mm), and SM per tissue section ranged from 0 to 2 mm. Seventy-four of 93 biopsies (80%) had <0.5 mm of SM, and 38 (41%) had no SM.
GCs were found within or subjacent to adherent muscularis mucosa in 63 of the 93 biopsies (68%) ( Table 1 and Figure 1) . A specific anatomic site was indicated in 12 of the 63 cases (19%) with GCs; these included 5 cases labeled ''rectum at 2 cm,'' 3 cases labeled ''rectum at 3 cm,'' and 1 case each labeled ''rectum at 2-3 cm,'' ''rectum at 3-4 cm,'' ''rectal wall at 2 mm,'' and ''rectal wall at 3 mm.'' Other biopsies with identified GCs were labeled ''rectum'' not otherwise specified (35 cases), In 46 of 63 cases in which GCs were identified (73%), there was a total of <0.5 mm (29 cases) or no (17 cases) submucosa. d Neither of the 2 patients on whose biopsies the CAL pattern was equivocal and in which no GCs were identified underwent further evaluation for HD.
''rectosigmoid'' (12), and 1 specimen each with ''distal rectum,'' ''sigmoid colon,'' ''ascending colon,'' and ''proximal colon.'' In 25 of 63 cases (40%), GCs were identified on one of the first 3 tissue sections examined. The median tissue section on which GCs were identified was the fifth section (range 1st-54th section). The 63 cases in which GCs were identified consisted of a median of 3 tissue fragments per biopsy (range 1-5 fragments) for a median of 6 mm of total mucosa (range 1-16 mm of mucosa). In 46 of 63 cases (73%), there was a total of less than 0.5 mm of SM, including 17 cases (27%) with no appreciable SM. All but one of these cases (62, 98%) showed positive CAL staining with a wide range of staining variability, including frequent weak staining; a single case showed CAL staining interpreted as equivocal.
Of the biopsies in which GCs were not observed (30 of 93, or 32%), most (22 of 30, or 73%) had no SM, and none (0%) had >1 mm of SM. A range of 6 to 98 total tissue sections had been prepared for these cases. There was a median of 3 fragments per biopsy (range 1-6 fragments) for a median of 5 mm of total mucosa (range 2-10 mm). In 7 of 30 biopsies (23%), a specific anatomic site was indicated: 3 cases as ''rectum at 2 cm'' and 4 cases ''rectum at 3 cm.'' Other biopsies were designated ''rectum'' not otherwise specified (12 cases), ''rectosigmoid'' (9), ''random colon'' (1), and ''distal colon'' (1). CAL was positive in 28 of 30 cases (93%) and equivocal/weak in 2 of 30 cases (7%) without observed GCs; as in the cases in which GCs were observed, CAL intensity was highly variable across this group. Chart review did not reveal further clinical or histologic evaluation for HD in any of the cases in which GCs were not identified.
Discussion
Our study demonstrates that in colonoscopic mucosal biopsies from children !1 year of age, sections frequently reveal GCs, often on early tissue levels and surprisingly often in the absence of submucosa. These routine RMBs often contained muscularis mucosa, within or subjacent to which GCs were identified in 68% (63 of 93) of examined cases. The data support our hypothesis that H&E sections in this setting can exclude aganglionosis at the level of the biopsy in many cases.
Identification of ganglion cells, however, is only useful for ruling out HD if a specific and appropriate anatomic biopsy site is designated by the endoscopist. A limitation of our study cohort is that a minority of the biopsies (19 of 93, 20%) were specified as rectal biopsies at 2 or 3 cm. These are the recommended sites for RSB 14, 15 because they are expected to avoid possible physiologic hypoganglionic zones in the distal most rectum 16 and nevertheless capture examples of short segment HD. Very short-or ultra short-segment HD cases are more likely to evade early diagnosis, 17 so appropriately located, and designated, biopsies are especially important in this !1 year of age patient population. Making inference about HD based on biopsies from undesignated or less specific anatomic sites (eg, ''rectum'' not otherwise specified), even if GCs are identified, is not recommended due to the dilemmas presented by transition zones of HD patients. Our data regarding GC identification and non-specific biopsy site labeling have served as the basis for ceasing performance of requested upfront CAL in undesignated mucosal colonoscopic biopsies at our institution, with CAL and/ or tissue levels instead ordered at the pathologist's discretion following review of initial H&E sections.
CAL has become a mainstay in the evaluation of RSBs for aganglionosis because, unlike acetylcholinesterase, it can be performed on FFPE tissue. 7, 8, 18 Calretininexpressing nerve fibers are normally present in the lamina propria and muscularis mucosae of ganglionated regions of bowel. 19 Typically, the diagnosis of HD relies on an adequate RSB with absence of identifiable GCs on tissue sections, absence of CAL expression, and an appropriate clinical scenario. Extrapolation of this concept to mucosal biopsies taken during colonoscopy has the potential to aid in the work-up of HD in select older children as well as in younger patients who undergo RSB with suboptimal SM sampling. To our knowledge, there are no existing data on CAL evaluation of mucosal (nonsuction) biopsies. One small retrospective study showed that in RSBs with inadequate submucosa (a scenario akin to RMBs), CAL accurately predicted presence or absence of GCs when compared to repeat RSBs, resection specimens, or robust clinical follow-up such that it was a useful aid in triaging further work-up. 20 That study included patients 1 year of age or older, but the lengths of the aganglionic segments were not specified, which may be significant because false-positive CAL has been reported in ultrashort HD. 21, 22 Our data have limitations that prevent additional inference about CAL utility in mucosal biopsies. The study could not calculate sensitivity and specificity for CAL because our cohort did not include any patients with confirmed HD or any examples of completely negative CAL. A prospective study of CAL staining in mucosal biopsies in confirmed HD and control patients could yield this information. The vast majority of biopsies in our series, 90 of 93 (97%), showed positive CAL expression. The significant staining variability across cases likely reflects technical factors, but possible tissue factors cannot be excluded. Technical challenges may be shared by other institutions, including but not limited to practices such as ours (shared with an adult practice) where CAL is most commonly used to evaluate mesothelial proliferations. Rigorously validated technical conditions for CAL would be required in a future study of its sensitivity and specificity for HD in mucosal biopsies, especially since the literature suggests sparse CAL staining may be a feature of very-short segment HD. 21 The cases with equivocal staining may have been technical failures, as neither of the 2 patients (or any others) without identified GCs underwent further work-up for constipation at our institution.
While CAL expression is considered sensitive, an important point is that it may not be entirely specific: calretinin-expressing nerve fibers in the lamina propria may extend beyond their site of origin and into adjacent transitional or aganglionic areas, 16 theoretically leading to false-positive CAL results if the biopsy occurs within this area. 8, 21, 22 Calretinin positivity has been documented 2 cm distal to GCs in the transition zone of resection specimens. 21 An adequately powered study designed to compare CAL staining in mucosal biopsies and RSBs (with sampled submucosa) in HD and control patients could address this concern. If such a study were to be carried out, it would be important to have biopsies taken at 2 and 3 cm per standard recommendations to exclude HD.
Based on our findings, we have recommended discontinuation of clinician-placed CAL orders on RMBs at our institution and their employment instead at the pathologist's discretion. In cases in which a biopsy is from an appropriate site for the work-up of HD and the PG desires information on the ganglionic state, a combination of serial H&E sections and CAL can be informative. A significant number of cases are expected to yield GCs and show positive CAL staining, allowing exclusion of HD and further work-up. Interpretation of CAL positivity without identification of GCs in mucosal biopsies performed at the proper location requires further study to address its utility, sensitivity, and specificity.
